RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side eff...

Apply for cancer research funding. Early-career oncology investigators compete live at Impact Pitch. Awards up to $50,000 tied to Binaytara conferences.

Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.

Regimen showed benefit in advanced head and neck cancer

CHICAGO — Fasting before and after chemotherapy may improve treatment response among women with high-grade serous ovarian cancer, according to findings presented at ASCO Annual Meeting.Study par...

Accumulating evidence of possible benefit warrants randomized trials, experts say

ASCO President Eric Small Honors The Impact of Volunteers / ASCO, cancer, Eric Small, OncoDaily, Oncology

Julie Gralow: Advocating for Sustained Federal Investment in Cancer Research / cancer, Julie Gralow, NCI, NIH, OncoDaily, Oncology

ASCO Breakthrough 2026 to Convene Global Oncology Community in Singapore / ASCO, ASCOBT26, cancer, Clifford Hudis, Elizabeth Mittendorf, Eric Small, Julie

ASCO Standards are evidence-based standards to provide frameworks for best practices in cancer care, following the standards development process as outlined in the ASCO Standards Policies and Procedur...

‏‏‎ ‎